These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9352592)

  • 21. The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder.
    Stratmann T; Apostolopoulos V; Mallet-Designe V; Corper AL; Scott CA; Wilson IA; Kang AS; Teyton L
    J Immunol; 2000 Sep; 165(6):3214-25. PubMed ID: 10975837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers.
    Liu CP; Jiang K; Wu CH; Lee WH; Lin WJ
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14596-601. PubMed ID: 11106373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition.
    Suri A; Walters JJ; Kanagawa O; Gross ML; Unanue ER
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5330-5. PubMed ID: 12682304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A conformationally-constrained MHC class II I-Ag7-derived peptide protects NOD mice from the development of diabetes.
    Dunsavage MB; O'Leary CJ; Baumgart TD; Solvason N; Howard M; Lafferty K; Deshpande S; Reich EP
    J Autoimmun; 1999 Jun; 12(4):233-42. PubMed ID: 10330294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
    J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of GAD65 peptides and I-Ag7 in the development of insulitis in nonobese diabetic mice.
    Ogino T; Sato K; Miyokawa N; Kimura S; Katagiri M
    Immunogenetics; 2000 Jun; 51(7):538-45. PubMed ID: 10912505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new look at MHC and autoimmune disease.
    Ridgway WM; Fassò M; Fathman CG
    Science; 1999 Apr; 284(5415):749, 751. PubMed ID: 10336398
    [No Abstract]   [Full Text] [Related]  

  • 29. Islet cell autoimmunity in NOD mice transgenic for HLA-DQ8 and lacking I-Ag7.
    Raju R; Munn SR; Majoribanks C; David CS
    Transplant Proc; 1998 Mar; 30(2):561. PubMed ID: 9532176
    [No Abstract]   [Full Text] [Related]  

  • 30. Islet cell autoimmunity in NOD mice transgenic to HLA-DQ8 and lacking I-Ag7.
    Raju R; Munn SR; Majoribanks C; David CS
    Transplant Proc; 1998 Mar; 30(2):474. PubMed ID: 9532134
    [No Abstract]   [Full Text] [Related]  

  • 31. Biochemical characterization of the human diabetes-associated HLA-DQ8 allelic product: similarity to the major histocompatibility complex class II I-A(g)7 protein of non-obese diabetic mice.
    Reizis B; Altmann DM; Cohen IR
    Eur J Immunol; 1997 Oct; 27(10):2478-83. PubMed ID: 9368599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization with an insulin peptide-MHC complex to prevent type 1 diabetes of NOD mice.
    Zhang L; Stadinski BD; Michels A; Kappler JW; Eisenbarth GS
    Diabetes Metab Res Rev; 2011 Nov; 27(8):784-9. PubMed ID: 22069260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
    Chosich N; Harrison LC
    Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First signature of islet beta-cell-derived naturally processed peptides selected by diabetogenic class II MHC molecules.
    Suri A; Walters JJ; Rohrs HW; Gross ML; Unanue ER
    J Immunol; 2008 Mar; 180(6):3849-56. PubMed ID: 18322192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Faulty major histocompatibility complex class I function linked to autoimmune diabetes.
    Faustman D
    Transplant Proc; 1992 Dec; 24(6):2874-6. PubMed ID: 1465979
    [No Abstract]   [Full Text] [Related]  

  • 36. The MHC class II molecule I-Ag7 exists in alternate conformations that are peptide dependent.
    Arneson LS; Peterson M; Sant AJ
    J Immunol; 2000 Aug; 165(4):2059-67. PubMed ID: 10925290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
    Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
    J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket.
    Suri A; Vidavsky I; van der Drift K; Kanagawa O; Gross ML; Unanue ER
    J Immunol; 2002 Feb; 168(3):1235-43. PubMed ID: 11801660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the expression of DR alpha E beta NOD molecule on the development of insulitis and diabetes in the non-obese diabetic (NOD) mouse.
    Yamane K; Yamamoto K; Yoshikawa Y; Sasazuki T
    Clin Exp Immunol; 1996 Jan; 103(1):141-8. PubMed ID: 8565273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of autoimmune diabetes in non-obese diabetic mice by treatment with a class II major histocompatibility complex-blocking peptide.
    Hurtenbach U; Lier E; Adorini L; Nagy ZA
    J Exp Med; 1993 May; 177(5):1499-504. PubMed ID: 8478620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.